Prevention of CRBSI in patients receiving hemodialysis through a central venous catheter

Catheter-related bloodstream infection in patients receiving hemodialysis through a central venous catheter refers to a severe systemic vascular infection originating directly from an indwelling dialysis catheter Pathophysiologically, repeated vascular access and catheter manipulation facilitate the migration and colonization of skin or environmental flora, leading to intraluminal or extraluminal biofilm formation, microbial seeding into the circulation, bacteremia, and high risks of sepsis, met...

Catheter-related bloodstream infection in patients receiving hemodialysis through a central venous catheter refers to a severe systemic vascular infection originating directly from an indwelling dialysis catheter Prevention in this vulnerable clinical cohort centers on mitigating pathogen entry and intraluminal colonization to protect systemic circulation and preserve viable vascular access

Catheter-related bloodstream infection in patients receiving hemodialysis through a central venous catheter refers to a severe systemic vascular infection originating directly from an indwelling dialysis catheter Pathophysiologically, repeated vascular access and catheter manipulation facilitate the migration and colonization of skin or environmental flora, leading to intraluminal or extraluminal biofilm formation, microbial seeding into the circulation, bacteremia, and high risks of sepsis, met...

This condition predominantly affects individuals with end-stage renal disease who rely on central venous access—such as tunneled or non-tunneled internal jugular, subclavian, or femoral lines—for extracorporeal renal replacement therapy

This condition predominantly affects individuals with end-stage renal disease who rely on central venous access—such as tunneled or non-tunneled internal jugular, subclavian, or femoral lines—for extracorporeal renal replacement therapy

This condition predominantly affects individuals with end-stage renal disease who rely on central venous access—such as tunneled or non-tunneled internal jugular, subclavian, or femoral lines—for extracorporeal renal replacement therapy

Prevention in this vulnerable clinical cohort centers on mitigating pathogen entry and intraluminal colonization to protect systemic circulation and preserve viable vascular access

Prevention in this vulnerable clinical cohort centers on mitigating pathogen entry and intraluminal colonization to protect systemic circulation and preserve viable vascular access